ORIGINAL ARTICLE |
|
Year : 2016 | Volume
: 29
| Issue : 4 | Page : 961-970 |
|
Prognostic impact of immunohistochemical stratification of diffuse large B-cell lymphoma into germinal and nongerminal subtypes
Nancy Y Asaad, Moshira M Abdel Wahed, Asmaa G Abdou, Marwa M Serag El-Dien, Mona A. H. Mohammed Kora MBBCH
Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt
Correspondence Address:
Mona A. H. Mohammed Kora Department of Pathology, Menoufia University, Shebin El Kom, 32511 Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1110-2098.202495
|
|
Objectives
The aim of this study was to investigate the difference between germinal and nongerminal diffuse large B-cell lymphoma (DLBCL) cases regarding their clinicopathological features, including survival and response to therapy.
Background
DLBCL is the most common subtype of non-Hodgkin's lymphoma in Egypt. It represents about 49% of non-Hodgkin's lymphoma cases according to the latest registry of National Cancer Institute, Cairo University. DLBCL is a heterogeneous group, especially as regards biological behavior, which includes response to chemotherapy and ultimate outcome. Previous studies suggested that classification of DLBCL into germinal and nongerminal subtypes had prognostic importance.
Patients and methods
This retrospective study included 61 de-novo DLBCL cases collected from the archival material of Pathology Department, Faculty of Medicine, Menoufia University, and treated at Menoufia Cancer Institute.
Results
Using Hans' algorithm, 31 (50.8%) cases were of germinal center B-cell (GCB) and 30 (49.8%) cases were of non-GCB subtype. Non-GCB cases showed significant association with splenic involvement (P = 0.01) and larger tumor size (P = 0.03). Overall, 90% of DLBCL cases with poor performance status were of GCB subtype. No significant difference regarding overall survival was noticed between GCB and non-GCB subtypes.
Conclusion
DLBCL should be classified into GCB and non-GCB subtypes because they differ prognostically. Hans' algorthim is a simple and reliable method for the classification of DLBCL, but it should be applied on a large number of cases to be used as a routine method for DLBCL evaluation. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|